Michael J. Farrell
Chairman of the Board and Chief Executive Officer, ResMed Inc.
Director Since 2014 ; Lead Independent Director Since 2025
Chief Executive Officer of ResMed Inc. since March 2013 and its Chairman of the Board since January 2023. Prior to his appointment as Chief Executive Officer, Mr. Farrell served as President, Americas for ResMed from 2011 to 2013. He was previously Senior Vice President of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development. Before joining ResMed in September 2000, Mr. Farrell worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Sanofi Genzyme, Dow Chemical and BHP. Mr. Farrell holds a bachelor of engineering, with first-class honors, from the University of New South Wales, a master of science in chemical engineering from the Massachusetts Institute of Technology and an MBA from the MIT Sloan School of Management.
Other Public Board Memberships
Other Relevant Experience
Member of the Compensation and Management Development Committee
Member of the Quality, Regulatory and Technology Committee